Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
  • Info
    • Permissions
    • Continuing Education
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
  • Info
    • Permissions
    • Continuing Education
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook
Nuclear Pharmacy

Criteria for Determining Optimal Pediatric Dosage for a Diagnostic Nuclear Medicine Procedure

Jake D. Helton, Tracey L. Barron and Joseph C. Hung
Journal of Nuclear Medicine Technology March 1996, 24 (1) 35-38;
Jake D. Helton
Nuclear Medicine, Department of Diagnostic Radiology, Mayo Clinic, Rochester, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tracey L. Barron
Nuclear Medicine, Department of Diagnostic Radiology, Mayo Clinic, Rochester, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph C. Hung
Nuclear Medicine, Department of Diagnostic Radiology, Mayo Clinic, Rochester, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Objective: The purpose of this paper is to provide information on the technical issues that must be addressed when adapting radiopharmaceuticals for use in children and to review the criteria and formulas currently used to calculate pediatric radiopharmaceutical dosages.

Methods: We conducted a phone survey of the nation’s top medical facilities for pediatric care to find the criteria employed to establish radiopharmaceutical dosing guidelines for children. Technical pediatric dosing considerations were also obtained from the medical literature.

Results: The majority of institutions surveyed use body weight as the sole criteria in the determination of pediatric dose and empirically derive their minimum allowable activity limits. Adult dosages, established at 70 kg, are used as the maximum allowable activity limits.

Conclusions: Although the medical literature supports the use of body surface area as one of the most reliable methods of calculating pediatric radiopharmaceutical dose, the majority of top pediatric health care facilities prefer to use body weight as the only variable in the calculation of optimal pediatric dosage. Given the importance of issues that must be considered to ensure the radiation safety and the physical and mental comfort of the child, we believe that all pediatric radiopharmaceutical dosing guidelines and considerations warrant further attention.

  • pediatric dosage
  • ALARA
  • body weight
  • body surface area
  • minimum and maximum allowable activity
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 24 (1)
Journal of Nuclear Medicine Technology
Vol. 24, Issue 1
March 1, 1996
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Criteria for Determining Optimal Pediatric Dosage for a Diagnostic Nuclear Medicine Procedure
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Criteria for Determining Optimal Pediatric Dosage for a Diagnostic Nuclear Medicine Procedure
Jake D. Helton, Tracey L. Barron, Joseph C. Hung
Journal of Nuclear Medicine Technology Mar 1996, 24 (1) 35-38;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Criteria for Determining Optimal Pediatric Dosage for a Diagnostic Nuclear Medicine Procedure
Jake D. Helton, Tracey L. Barron, Joseph C. Hung
Journal of Nuclear Medicine Technology Mar 1996, 24 (1) 35-38;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • Standardization of Administered Activities in Pediatric Nuclear Medicine: A Report of the First Nuclear Medicine Global Initiative Project, Part 2--Current Standards and the Path Toward Global Standardization
  • Google Scholar

More in this TOC Section

  • Evaluation of an Alternative Radiochemical Purity Testing Method for Technetium-99m-Sestamibi
  • Experimental Determination of Dose Calibrator Settings and Study of Associated Volume Dependence in V-Vials for Rhenium-186 Perrhenate Solution Sources
  • The Effect of Vincristine on the Biodistribution of Technetium-99m DTPA, GHA, and DMSA in Balb/c Female Mice
Show more Nuclear Pharmacy

Similar Articles

Keywords

  • pediatric dosage
  • ALARA
  • body weight
  • body surface area
  • minimum and maximum allowable activity
SNMMI

© 2021 Journal of Nuclear Medicine Technology

Powered by HighWire